Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, July 1, 2022

FDA approves nitric oxide generator to treat neonates with hypoxic respiratory failure

 With all the benefits of nitric oxide, what is your doctor's protocol to make sure you're getting the right amount? Or doesn't your doctor even know about nitric oxide?

FDA approves nitric oxide generator to treat neonates with hypoxic respiratory failure

Beyond Air has received FDA approval for its nitric oxide generator and delivery system to treat term and near-term neonates with hypoxic respiratory failure, according to a company press release.

LungFit PH generates on-demand unlimited nitric oxide from ambient air using patented ionizer technology and delivers it to a ventilator circuit, regardless of dose or flow. Using a compressor, LungFit PH drives room air through a plasma chamber of electrical pulses equivalent to a 60 W lightbulb to ionize the nitrogen and oxygen molecules to create nitric oxide, which is then passed through a filter removing the toxic nitrogen dioxide. This platform was designed and built by the inventors who created the first nitric oxide delivery system and subsequent systems currently in use today, according to the release.

Baby in an NICU
Source: Adobe Stock.

“The FDA approval of LungFit PH enables a new era of nitric oxide therapy and marks a pivotal event for Beyond Air as we officially enter the U.S. market,” Steve Lisi, CEO and chairman of Beyond Air, said in the release. “As the first and only approved nitric oxide generator and delivery system, LungFit PH empowers health care providers to maximize the efficiency of a hospital when treating [pulmonary hypertension of the newborn] by moving beyond their reliance on traditional, inefficient delivery systems and the associated burdensome logistics and safety requirements.”

To treat pulmonary hypertension of the newborn, LungFit PH is designed to deliver a nitric oxide dosage to the lungs consistent with the current standard of care for delivery of 20 ppm nitric oxide with a range of 0.5 ppm to 80 ppm for ventilated patients. The filter within the system lasts 12 hours regardless of ventilator demands.

“We believe that LungFit PH is just the first in a series of our medical devices that, if approved, will become available for treating a wide variety of respiratory diseases as we remain dedicated to our mission of harnessing the power of nitric oxide for all who can benefit from this transformational therapy,” Lisi said.

Beyond Air will be working with select hospitals to make LungFit PH available with a broader nationwide launch expected in the first half of 2023.

No comments:

Post a Comment